Abstract -This paper reports the results of a 3-week drinking experiment in 51 healthy male subjects, examining the value of %CDT (carbohydrate-deficient transferrin) in the context of different levels of alcohol intake. All healthy persons were urine-tested drug-free and underwent daily breath alcohol tests for the 7 days preceding, and during the whole 3 weeks of, the experiment. Subjects were divided into five groups, consuming different amounts of alcohol daily over a 3-h period in the presence of the investigators. The five groups consisted of 10, 9,10, 16 and 6 subjects respectively and consumed a daily dose of ethanol of 20, 40, 60, 80 and 80 g respectively for 3 weeks. No significant changes in %CDT were detected in most subjects, even in the 80 g alcohol-consuming groups. The results suggest that CDT is not sensitive for the detection of short-term heavy drinking by healthy subjects.
INTRODUCTION
Normal serum transferrin has several polysaccharide side-chains, a deficiency in which appears to be induced by alcohol consumption (Stibler et al, 1979 (Stibler et al, , 1986 . The resulting carbohydrate-deficient transferrin (CDT) was introduced as a 'state marker' for chronic alcohol abuse by Stibler and Borg (1988) and this was followed by many investigations of this marker in different clinical situations (for references, see the preceding two papers by Lesch et al., 1996a,b) . In these two papers, we investigated the value of CDT as a marker of alcohol consumption in a general hospital population and in alcohol-dependent subjects respectively.
In their discussion of state markers, Rosman and Lieber (1992) suggested that these could be further subdivided into two groups of markers, 'screening markers' for chronic alcohol consumption and 'relapse markers' for acute alcohol consumption. At present, it is not certain if CDT can serve both as a screening and a relapse marker (see also Allen et al, 1994) . Borg et al. (1992) and Borg (1993) stated that daily consumption of at least 60 g of ' Author to whom correspondence should be addressed. alcohol for 10 days or more increases CDT values (measured in absolute units), implying that CDT could serve as a relapse marker. In the preceding paper (Lesch et al., 1996£>) , we found, however, that %CDT does not correlate with blood ethanol concentration at the time of admission nor with pattern and duration of alcohol consumption during the 2 months preceding detoxification.
In the present paper, we have investigated the possible suitability of CDT as a relapse marker, by measuring its level following a controlled drinking experiment in healthy volunteers.
SUBJECTS AND METHODS

Subjects and design
Fifty-one male volunteers participated in the study. Initially, we had planned to investigate 45 subjects divided into four groups. For reasons given below, we included a fifth group of six subjects. The participants and their first degree relatives, as well as their other family members, had no history of alcoholism, other addictions or psychiatric disease. All participants were only occasional social drinkers and had normal gammaglutamyl transferase (GGT) values. daily alcohol dose consumed over 3 h for the 3 week experimental period. Because we could not demonstrate changes in %CDT values, even in subjects of group 4, who consumed the largest dose of ethanol (80 g daily for 3 weeks), a fifth group was added to the study, consisting of six subjects all of whom were given the above dose of ethanol as in group 4, and whose alcohol intake during the experiment was followed hourly with a breathalyser.
Determination of CDT
CDT was measured in most experiments as a percentage. However, because the observation by Borg et al. (1992) and Borg (1993) that CDT is elevated after 10 days of daily consumption of at least 60 g of ethanol was made in absolute (mg/1), rather than relative (%) units of CDT, a comparison of our Axis procedure (see below) with that used by the group of Borg (Pharmacia, 1990) was made in the present work, and has demonstrated a very good correlation ( Fig. 1 ).
For measurement of %CDT, serum was frozen at -30 °C and was sent to Axis Biochemicals Laboratories in Norway. The period between venesection and analysis of samples did not exceed 3 months. The principle of the Axis %CDT test is briefly as follows: labelled 125 Iantibody fragments are allowed to react with an excess of transferrin in the serum sample. After a 10 min incubation, the mixture is passed through a single use ion-exchange column, followed by two elution steps. During the first elution step, nonspecific bound labelled antibody is separated, whereas in the second elution step low sialic acid transferrin is collected in the eluate. The radioactivity of the second-step eluate is interpolated on a calibration curve, yielding the %CDT value of the serum sample. The cut-off point for a pathological result was fixed at >2.4% CDT. The %CDT was determined in blood samples taken before and on days 3, 7,14 and 21 after the start of experimental alcohol consumption period.
Other measurements
Sera of the subjects were also analysed for gamma-glutamyl transferase, aspartate aminotransferase and alanine aminotransferase activities using standard clinical laboratory techniques. 
RESULTS
The results in Tables 2-6 show generally that experimental alcohol consumption by normal subjects of daily doses of 20, 40, 60, 80 and 80 g respectively over a 3-week period was not associated with elevation of %CDT values in serum. There were, however, a few exceptions, which will be described below. In the Tables,  individual values for each subject are given, with no means or statistical analysis. This is because, apart from the few exceptions described below, there were no differences between subject or even group means or following the experimental drinking period, and we also considered it more informative to present data for each subject individually.
A glance at the zero-time data (i.e. before the start of the drinking experiment) in Tables 2-6 shows that most subjects had %CDT values well within the normal range of 0-2.4%; only a few had values at or near the upper normal point of 2.4% (subject 8 in Table 3 , subject 8 in Table 4 , subjects 12 and 14 in Table 5 and subject 3 in Table 6 ). In some of these subjects, the %CDT value was decreased at the end of the 3 week observation period. Additionally, as stated above, there were a few exceptions to the general trend of decreasing %CDT with time. Thus, in addition to six subjects in Table 3 showing a very mild increase in %CDT with time, subject 6 in Table 4 showed no significant change in %CDT from the initial high value of 9.2% on day 0, whereas subjects 8 in Table 4 , 2 and 13 in Table 5 and 3 in Table 6 actually showed increases in %CDT during the 3 week experimental period, from 2.0 to 3.6, 1.3 to Table 5 . 2.9,1.0 to 3.8 and 2.4 to 2.9 respectively. Subjects in whom the %CDT values were high before the start of the experiment admitted a higher alcohol intake and drinking for a longer period of time than initially stated, and some of them have been entered into a treatment programme. As stated in the Subjects and methods section, a fifth group of subjects was studied after investigation of those of the first four groups, because the outcome of the study of subjects in group 4 showed no change in %CDT after drinking 80 g of ethanol daily for 3 weeks. The six subjects in the fifth group were given a similar daily dose of alcohol (80 g for a 3 week period), but their experimental daily alcohol intake over the specified 3 h period was monitored hourly using a breathalyser. As stated above, only one subject (no. 3) in this group showed a modest increase in %CDT from a starting value of 2.4% on day 0 to 2.9% on day 21 (Table 6 ). This subject is now a patient receiving regular treatment. An example of breath ethanol analysis in one subject (no. 2) in the fifth group is shown in Table 7 . It is clear from the results that breath ethanol levels varied widely Table 6 . %CDT in subjects drinking 80 g of alcohol daily (group 5) In data not detailed here, we observed no major differences between subjects nor in subjects over the 3-week experimental period in serum levels of gamma-glutamyl transferase, aspartate aminotransferase and alanine aminotransferase.
DISCUSSION
The development of a biological marker is of great importance for identification and classification of alcohol abuse and dependence. Diagnostic systems, such as ICD-10 or DSM-IV, are most suitable for epidemiological studies, but not so in basic research or objective diagnosis of alcohol consumption (Litten and Allen, 1992; Sobell and Sobell, 1992; Lesch et al, 1990 Lesch et al, , 1993 . In the present study, we have examined the value of CDT as a marker of alcohol consumption in normal subjects by performing a controlled drinking experiment. Although the experimental conditions (drinking a fixed dose of alcohol for the same 3 h duration daily at the hospital) were controlled, we could not exclude the possibility that the subjects may have consumed additional amounts of alcohol in the evenings. However, because their breath alcohol level was always 0 in the mornings and the majority of the %CDT values remained low throughout the experiment, the above possibility seems unlikely.
As the results in Tables 2-6 show, no general elevation in CDT levels was seen even after consumption of 80 g of ethanol daily for 3 weeks. Only a few subjects showed an elevation, which was only of a moderate extent. Borg et al. (1992) and Borg (1993) stated that a daily consumption of 60 g of alcohol at least for 10 days is a prerequisite for elevation of CDT in both normal and alcoholic subjects. The present results in normal subjects do not support those obtained by these latter authors. Our preceding paper (Lesch et al, 19966) also shows no correlation between %CDT values and extent, pattern or duration of alcohol consumption in alcohol-dependent subjects before detoxification, though elevation of CDT was associated with very high alcohol consumption. The differences between our results and those of the group of Borg cannot be explained completely satisfactorily at present. However, some of the following explanations are possible. The response of normal subjects to alcohol consumption as regards CDT elevation may be different from that of alcohol-dependent subjects. Thus, Behrens et al. (1988) postulated that sensitization occurs in regular drinkers, and it has also been shown (Behrens et al., 1988; Bell et al., 1993; Borg, 1993) that CDT can depict individuals with chronic alcohol intake. Previous drinking experiments in children of alcoholdependent, and of non-alcoholic, subjects have also revealed differences between the two groups concerning other aspects of alcohol actions, e.g. ethanol pharmacokinetics and metabolism, alcohol-related behavioural changes and other biological and neurological parameters, though sometimes with divergent results (Schuckit, 1984; Newlin, 1985; O'Malley and Maisto, 1985; Finn and Pihl, 1987; Schuckit, 1988; DeWitte and McCracken, 1990; Pollock, 1992) . As regards the above 'sensitization', it is possible that episodic drinking in Scandinavia and Northern Europe may induce responses (in CDT) to alcohol consumption different from those made by subjects in wine-producing regions of middle and Southern Europe with different consumption patterns and hence possibly differences in hepatic sensitivity, somatic functions and even mortality (Lesch, 1985; Lesch et al, 1986; Poldrugo et al, 1993) .
It is noteworthy that none of the subjects in group 1 consuming the lowest dose of alcohol (20 g daily) was alcohol-dependent. This suggests that a high-dose drinking experiment in the general population is likely to attract some alcohol-dependent subjects and this possibility should always be kept in mind.
In conclusion, we suggest that Northern Europeans should be compared with Middle and Southern Europeans as regards the CDT status among chronic alcoholics and other heavy drinkers and also after experimental alcohol consumption in non-alcoholic controls, to ascertain whether any differences in CDT are present and, if so, what precise factors are likely to be responsible for such differences.
